The revision comes after encouraging Phase 2 data for Merus’ drug candidates petosemtamab and pembrolizumab (pembro) were ...

Raymond James downgraded Booz Allen Hamilton Holding Corporation (NYSE:BAH) from Outperform to Market Perform on May 24, without a price target, following the company ...

TD Cowen updated its evaluation of JPMorgan Chase & Co. (NYSE:JPM), raising its price target from $305 to $315 while ...

A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as ...

Spacs are experiencing something of a comeback thanks to the Lutnick empire, which is now led by Howard’s children and a triumvirate of bankers including infamous healthcare dealmaker Sage Kelly .

U.S. President Donald Trump approved the merger of United States Steel Corporation (NYSE:X) and Nippon Steel on May 23, ...

JPMorgan Chase & Co. (NYSE:JPM) revealed its Center for Geopolitics (CfG), a new advisory division that offers the bank’s ...

JPMorgan reaffirmed its Overweight rating and $255 price target for L3Harris Technologies Inc. (NYSE:LHX), following a ...

There is a lot of macro "noise" in the market right now, as one Wall Street analyst called it, with higher tariffs, changes ...

Bernstein analysts reaffirmed their Market Perform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on May 20, ...